Indivior to Participate in Upcoming Conferences

RNS Number : 7452E

Indivior PLC

10 November 2020

 

Indivior Announces Participation in Upcoming Investor Conferences

Slough, United Kingdom and Richmond, Virginia - November 10, 2020 - Indivior PLC (LON: INDV) today announced its participation in the following upcoming investor conferences:

· November 16^th, 8:00 AM US Eastern Time (ET): Stifel Virtual Healthcare Conference ( link ).

· November 17^th, 12:00 PM US Eastern Time (ET): Jefferies Virtual Global Healthcare Conference ( link ).

About Indivior 

Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat addiction and serious mental illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of addiction. Indivior is dedicated to transforming addiction from a global human crisis to a recognized and treated chronic disease. 

Building on its global portfolio of opioid dependence treatments, Indivior has a pipeline of product candidates designed to both expand on its heritage in this category and potentially address other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder. Headquartered in the United States in Richmond, VA, Indivior employs more than 700 individuals globally and its portfolio of products is available in over 40 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior .  

For Further Information

Investor Enquiries	Jason Thompson	VP, Investor Relations Indivior PLC	[phone] [e-mail]
Media Enquiries	Jonathan Sibun	Tulchan Communications US Media Inquiries	[phone]   [phone] [e-mail]

-ends-

 

END

 

 

MSCEAPFNEDLEFFA